Evidence map›Paper›PMID 31605258›Full record

ReviewMetabolic brain disease2020

Awareness and current knowledge of epilepsy.

Asmat Ullah Khan, Muhammad Akram, Muhammad Daniyal, Naheed Akhter, Muhammad Riaz, Naheed Akhtar, Mohammad Ali Shariati, Fozia Anjum, Samreen Gul Khan, Abida Parveen and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Metabolic brain disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Progress on mitochondrial silence information regulator family in epilepsy.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2021
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Asmat Ullah KhanDepartment of Eastern Medicine, The University of Poonch, Rawalakot, Azad Jammu and Kashmir, Pakistan.
Muhammad AkramDepartment of Eastern Medicine, Government College University, Faisalabad, Pakistan.
Muhammad DaniyalTCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Materia Medica Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
Naheed AkhterCollege of Allied Health Professional, Government College University, Faisalabad, Pakistan.
Muhammad RiazDepartment of Allied Health Sciences, Sargodha Medical College, University of Sargodha, Sargodha, Pakistan.
Naheed AkhtarDepartment of Pharmacy, The University of Poonch, Rawalakot, Azad Jammu and Kashmir, Pakistan.
Mohammad Ali ShariatiKazakh Research Institute of Processing and Food industry (Semey branch), Semey, Kazakhstan.
Fozia AnjumDepartment of Chemistry, Government College University, Faisalabad, Pakistan.
Samreen Gul KhanDepartment of Chemistry, Government College University, Faisalabad, Pakistan.
Abida ParveenDepartment of Botany, Government College University, Faisalabad, Pakistan.
Saeed AhmadUniversity College of Agriculture, University of Sargodha, Sargodha, Pakistan. saeedpirzada75@gmail.com.ORCID 0000-0001-9291-7059
Government College University, Faisalabad · PKUniversity of Azad Jammu and Kashmir · PKUniversity of Sargodha · PKHunan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is a severe neural disorder that affects approximately fifty million individuals globally. Despite the fact that for most of the people with epilepsy, convulsions are better controlled by current accessible antiepileptic medicines, yet there are more than 30% of individuals affected with medically intractable epilepsy and around 30-40% of all patients with epilepsy affected by many adverse reactions and convulsion resistance to the present antiepileptic drugs. Consequently, various scientists attempt to develop new strategies to treat epilepsy, for instance, to find out novel antiepileptic ingredients from traditional medicines. This work aims to present a complete summary of natural medicines prescribed as antiepileptic agents all over the world by ethnic groups and different tribes. We undertook an extensive bibliographic analysis by searching peer reviewed papers and classical textbooks and further consulting well accepted worldwide scientific databases. We carried out PubMed, EMbase and CENTRAL searches by means of terms such as "antiepileptic" and "anti-convulsant" activity of plants. Medicinal plants have been prescribed to treat epilepsy and have been recognized as antiepileptic medicines. In this review, a variety of herbs have been reviewed for thorough studies such as Cuminum cyminum, Butea monosperma, Solanum americanum, Anacyclus pyrethrum, Leonotis leonurus, Elaeocarpus ganitrus and Angelica archangelica. This paper shows that it was high time experimental studies are increased to obtain novel potential active principles from medicinal plants. Plant extracts and their chemical constituents should be further evaluated to clarify their mechanisms of action. This paper provides a solid base upon which to further investigate the clinical efficacy of medicinal plants that are both currently prescribed by physicians as traditional antiepileptic agents, but also could be effective as an antiepileptic drug with further research and study.

Indexed as

AwarenessHealth Knowledge, Attitudes, PracticeAnimalsAnticonvulsantsEpilepsyHumansMedicine, TraditionalPhytotherapyPlant ExtractsAnticonvulsantsPlant ExtractsChemical compoundsEpilepsyMedicinal plantsPhytotherapy

Identifiers

PMID31605258
OpenAlexW2979568282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.